Spyre Therapeutics, Inc.
| CIK |
Ticker |
Name |
Accession Number |
Date |
Form |
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001636282-24-000021 |
2024-04-01 16:06:29 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001636282-24-000018 |
2024-03-20 07:14:05 |
PRE 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-23-264329 |
2023-10-26 21:53:28 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-23-205262 |
2023-08-07 21:51:27 |
PRE 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-23-103731 |
2023-04-17 16:47:57 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-23-095201 |
2023-04-07 16:02:57 |
PRE 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-22-015010 |
2022-04-21 08:30:43 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-21-019953 |
2021-04-22 08:30:12 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-20-018057 |
2020-04-23 08:30:33 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-19-012157 |
2019-04-22 08:00:19 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-18-022770 |
2018-09-06 17:00:18 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-18-008198 |
2018-04-16 07:00:32 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-17-006805 |
2017-04-21 08:01:19 |
DEF 14A
|
